Canada Markets close in 2 hrs 33 mins

Orchard Therapeutics plc (ORTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.4050-0.0750 (-3.02%)
As of 4:00PM EDT. Market open.
Sign in to post a message.
  • P
    Paul
    Why are Insiders NOT buying ORTX? Is it that they have no confidence?
  • P
    Paul B
    $3.00 looks so far away now
  • k
    k
    What Ortex has is a method of treatment, a technique, not only for rare diseases. They used rare disases to prove it, but they can transfer the method for use against other diseases. Nearly zero side effects, because they use the probands own cells. The cells reached the brain of the probands, that is difficult to achieve with other kind of chemical treatments. So there is clearly a need with other diseases too. Additionally they spoke about chronic colitis as a target at the last presentation.
  • P
    Paul
    ORTX is NO MTEM
    $4.5 Million Institutional Buy 09/21/2021
    https://www.sec.gov/Archives/edgar/data/924223/000089924321037292/xslF345X03/doc4.xml
    ORTX is NO MTEM
    SEC FORM 4
    www.sec.gov
  • P
    Paul
    If the Market ORTX serves is 1 person in every 40,000; relative to other BioPharma, ORTX's Market is VERY SMALL.

    Illness: ___________________ Prevalence
    Breast Cancer (Female): 1 in 8
    Prostate Cancer (Male): 1 in 8
    Lung and Bronchus Cancer: 1 in 16
    Cardiovascular disease: 1 in 18
    Colorectal Cancer: 1 in 24
    Uterine Cancer: 1 in 32
    Bladder Cancer: 1 in 42
    Melanoma of the Skin: 1 in 43
    Non-Hodgkin Lymphoma: 1 in 48
    Pancreatic cancer: 1 in 59
    Kidney and Renal Pelvis Cancer: 1 in 59
    Leukemia: 1 in 63
    Crohn's disease: 1 in 77
    Cervical cancer: 1 in 167
    Laryngeal cancer: 1 in 333
    Hodgkin Lymphoma: 1 in 500
    Duchenne muscular dystrophy (males): 1 in 6,250
    Huntington's disease: 1 in 11,104
    Metachromatic leukodystrophy (ORTX): 1 in 40,000 to 160,000
    Adenosine deaminase deficiency (ORTX): 1 in 200,000 to 1,000,000
  • P
    Paul
    ORTX is DOWN 72.8% from it's high of $9.08
    NO Insider Buying
    NO Market, or Very Small Market, for it's drugs.
    NO Insider Confidence.
  • K
    Keith
    Nice day! Assuming news I haven't seen yet.
  • P
    Paul
    The Pumpers are at it again.
    NO Insider Buying & a Very Small Market.

    If the Market ORTX serves is 1 person in every 40,000; relative to other BioPharma, ORTX's Market is VERY SMALL.

    Illness: ___________________ Prevalence
    Breast Cancer (Female): 1 in 8
    Prostate Cancer (Male): 1 in 8
    Lung and Bronchus Cancer: 1 in 16
    Cardiovascular disease: 1 in 18
    Colorectal Cancer: 1 in 24
    Uterine Cancer: 1 in 32
    Bladder Cancer: 1 in 42
    Melanoma of the Skin: 1 in 43
    Non-Hodgkin Lymphoma: 1 in 48
    Pancreatic cancer: 1 in 59
    Kidney and Renal Pelvis Cancer: 1 in 59
    Leukemia: 1 in 63
    Crohn's disease: 1 in 77
    Cervical cancer: 1 in 167
    Laryngeal cancer: 1 in 333
    Hodgkin Lymphoma: 1 in 500
    Duchenne muscular dystrophy (males): 1 in 6,250
    Huntington's disease: 1 in 11,104
    Metachromatic leukodystrophy (ORTX): 1 in 40,000 to 160,000
    Adenosine deaminase deficiency (ORTX): 1 in 200,000 to 1,000,000
  • T
    TJ
    Great news today! 3 new key senior level appointments. Proven backgrounds in genetic and car-t research. Senior level experience at Biogen, Novartis, etc. Staying the course with a therapeutic approach based on novel and sound science.
  • P
    Paul
    Would you prefer to invest in a Pharma Co serving 1 in every 8 people, or 1 in every 100,000 people?
  • P
    Peter
    Let’s see 3$! And then, let’s go 🚀!
  • P
    Paul
    EDGAR Search Results
    www.sec.gov
  • J
    Joe
    The short squeeze has begun! here we go
  • P
    Paul
    ORTX is DOWN 72.8% from it's high of $9.08 & GOING NO Where.
    NO Insider Buying
    NO Market, or Very Small Market, for it's drugs.
    NO Insider Confidence.
  • P
    Paul B
    Glad I only had a couple hundred shares for the ride down from mid 7s. Bought on JP Morgan’s recommendation. Would like to add but I’m not a gambler. Will just hope for the morning I awaken to it at $10 due to some news event.😍👍
  • P
    Paul
    Which BioPharma company is in the Right Market?
    Compare the Prevalences of diseases for yourself.
    Illness: ___________________ Prevalence
    Breast Cancer (Female): 1 in 8
    Prostate Cancer (Male): 1 in 8
    Lung and Bronchus Cancer: 1 in 16
    Cardiovascular disease: 1 in 18
    Colorectal Cancer: 1 in 24
    Uterine Cancer: 1 in 32
    Bladder Cancer: 1 in 42
    Melanoma of the Skin: 1 in 43
    Non-Hodgkin Lymphoma: 1 in 48
    Pancreatic cancer: 1 in 59
    Kidney and Renal Pelvis Cancer: 1 in 59
    Leukemia: 1 in 63
    Crohn's disease: 1 in 77
    Cervical cancer: 1 in 167
    Laryngeal cancer: 1 in 333
    Hodgkin Lymphoma: 1 in 500
    Duchenne muscular dystrophy (males): 1 in 6,250
    Huntington's disease: 1 in 11,104
    Metachromatic leukodystrophy (ORTX): 1 in 40,000 to 160,000
    Adenosine deaminase deficiency (ORTX): 1 in 200,000 to 1,000,000
  • J
    JoeB
    Rename this to the “Paul” message board.. my god
  • A
    Andy
    I never thought this would be one of the worst performing stocks that I have ever owned.
  • Y
    Yahoo Finance Insights
    Orchard Therapeutics is up 5.28% to 2.59
  • P
    Paul
    To you Pumpers, If you are Insiders, you are Violating the Law.